XML 16 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Shareholder’s Equity - USD ($)
$ in Thousands
Preferred A Shares Microbot Medical Ltd. Pre-Merger [Member]
 [1]
Preferred A Shares Microbot Medical Inc. Post-Merger [Member]
 [1]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Temporary Equity [Member]
Balance at Dec. 31, 2015 $ 87 $ 132 $ 3,089 $ (3,372) $ (64)
Balance, shares at Dec. 31, 2015 8,708,132 13,182,660        
Conversion of convertible notes and exercise of warrants issued upon conversion $ 48 1,803 1,851
Conversion of convertible notes and exercise of warrants issued upon conversion, shares 4,746,237        
Effect of reverse recapitalization $ (135) $ 153 454 472
Effect of reverse recapitalization, shares (13,454,369) 15,301,675        
Common stock classified as temporary equity (500) (500) 500
Beneficial Conversion Feature recorded on convertible debt acquired in reverse recapitalization 2,029 2,029
Transaction costs incurred in reverse recapitalization $ 78 6,817 6,895
Transaction costs incurred in reverse recapitalization, shares 7,802,639        
Cancellation of ordinary shares and issuance of preferred shares [2] $ (97) 97
Cancellation of ordinary shares and issuance of preferred shares, shares 9,736 (9,736,000)        
Share based compensation 676 $ 676
Exercise of options, shares            
Net loss (9,663) $ (9,663)
Balance at Dec. 31, 2016 [2] $ 266 14,465 (13,035) 1,696 500
Balance, shares at Dec. 31, 2016 9,736 26,550,974 [3]        
Share based compensation $ 1 478 479
Share based compensation, shares 120,000        
Issuance of common stock $ 45 12,657 12,702
Issuance of common stock, shares 4,450,000        
Exercise of options $ 4 (4)
Exercise of options, shares 471,794     (471,794)  
Cashless exercise of warrants [2] [2]
Cashless exercise of warrants, shares 359        
Extinguishment of convertible notes and issuance of preferred A shares [2] 2,676 2,676
Extinguishment of convertible notes and issuance of preferred A shares, shares 3,255        
Conversion of preferred A shares to common stock [2] $ 90 (90)
Conversion of preferred A shares to common stock, shares (8,990) 8,990,000        
Net loss (7,589) (7,589)
Balance at Dec. 31, 2017 [2] $ 406 $ 30,182 $ (20,624) $ 9,964 $ 500
Balance, shares at Dec. 31, 2017 4,001 40,583,127 [3]        
[1] Share data for periods prior to the reverse recapitalization represents the legal equity structure of Microbot Medical Ltd. with the number of shares adjusted to retroactively reflect the one-to-nine Reverse Stock Split effected on November 28, 2016 as well as the reverse recapitalization consummated on November 28, 2016.
[2] Less than 1
[3] Includes 10,702,838 common stock classified as temporary equity.